Cargando…

iADRGSE: A Graph-Embedding and Self-Attention Encoding for Identifying Adverse Drug Reaction in the Earlier Phase of Drug Development

Adverse drug reactions (ADRs) are a major issue to be addressed by the pharmaceutical industry. Early and accurate detection of potential ADRs contributes to enhancing drug safety and reducing financial expenses. The majority of the approaches that have been employed to identify ADRs are limited to...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Xiang, Cheng, Meiling, Yu, Liyi, Xiao, Xuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786008/
https://www.ncbi.nlm.nih.gov/pubmed/36555858
http://dx.doi.org/10.3390/ijms232416216
_version_ 1784858187738906624
author Cheng, Xiang
Cheng, Meiling
Yu, Liyi
Xiao, Xuan
author_facet Cheng, Xiang
Cheng, Meiling
Yu, Liyi
Xiao, Xuan
author_sort Cheng, Xiang
collection PubMed
description Adverse drug reactions (ADRs) are a major issue to be addressed by the pharmaceutical industry. Early and accurate detection of potential ADRs contributes to enhancing drug safety and reducing financial expenses. The majority of the approaches that have been employed to identify ADRs are limited to determining whether a drug exhibits an ADR, rather than identifying the exact type of ADR. By introducing the “multi-level feature-fusion deep-learning model”, a new predictor, called iADRGSE, has been developed, which can be used to identify adverse drug reactions at the early stage of drug discovery. iADRGSE integrates a self-attentive module and a graph-network module that can extract one-dimensional sub-structure sequence information and two-dimensional chemical-structure graph information of drug molecules. As a demonstration, cross-validation and independent testing were performed with iADRGSE on a dataset of ADRs classified into 27 categories, based on SOC (system organ classification). In addition, experiments comparing iADRGSE with approaches such as NPF were conducted on the OMOP dataset, using the jackknife test method. Experiments show that iADRGSE was superior to existing state-of-the-art predictors.
format Online
Article
Text
id pubmed-9786008
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97860082022-12-24 iADRGSE: A Graph-Embedding and Self-Attention Encoding for Identifying Adverse Drug Reaction in the Earlier Phase of Drug Development Cheng, Xiang Cheng, Meiling Yu, Liyi Xiao, Xuan Int J Mol Sci Article Adverse drug reactions (ADRs) are a major issue to be addressed by the pharmaceutical industry. Early and accurate detection of potential ADRs contributes to enhancing drug safety and reducing financial expenses. The majority of the approaches that have been employed to identify ADRs are limited to determining whether a drug exhibits an ADR, rather than identifying the exact type of ADR. By introducing the “multi-level feature-fusion deep-learning model”, a new predictor, called iADRGSE, has been developed, which can be used to identify adverse drug reactions at the early stage of drug discovery. iADRGSE integrates a self-attentive module and a graph-network module that can extract one-dimensional sub-structure sequence information and two-dimensional chemical-structure graph information of drug molecules. As a demonstration, cross-validation and independent testing were performed with iADRGSE on a dataset of ADRs classified into 27 categories, based on SOC (system organ classification). In addition, experiments comparing iADRGSE with approaches such as NPF were conducted on the OMOP dataset, using the jackknife test method. Experiments show that iADRGSE was superior to existing state-of-the-art predictors. MDPI 2022-12-19 /pmc/articles/PMC9786008/ /pubmed/36555858 http://dx.doi.org/10.3390/ijms232416216 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Cheng, Xiang
Cheng, Meiling
Yu, Liyi
Xiao, Xuan
iADRGSE: A Graph-Embedding and Self-Attention Encoding for Identifying Adverse Drug Reaction in the Earlier Phase of Drug Development
title iADRGSE: A Graph-Embedding and Self-Attention Encoding for Identifying Adverse Drug Reaction in the Earlier Phase of Drug Development
title_full iADRGSE: A Graph-Embedding and Self-Attention Encoding for Identifying Adverse Drug Reaction in the Earlier Phase of Drug Development
title_fullStr iADRGSE: A Graph-Embedding and Self-Attention Encoding for Identifying Adverse Drug Reaction in the Earlier Phase of Drug Development
title_full_unstemmed iADRGSE: A Graph-Embedding and Self-Attention Encoding for Identifying Adverse Drug Reaction in the Earlier Phase of Drug Development
title_short iADRGSE: A Graph-Embedding and Self-Attention Encoding for Identifying Adverse Drug Reaction in the Earlier Phase of Drug Development
title_sort iadrgse: a graph-embedding and self-attention encoding for identifying adverse drug reaction in the earlier phase of drug development
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786008/
https://www.ncbi.nlm.nih.gov/pubmed/36555858
http://dx.doi.org/10.3390/ijms232416216
work_keys_str_mv AT chengxiang iadrgseagraphembeddingandselfattentionencodingforidentifyingadversedrugreactionintheearlierphaseofdrugdevelopment
AT chengmeiling iadrgseagraphembeddingandselfattentionencodingforidentifyingadversedrugreactionintheearlierphaseofdrugdevelopment
AT yuliyi iadrgseagraphembeddingandselfattentionencodingforidentifyingadversedrugreactionintheearlierphaseofdrugdevelopment
AT xiaoxuan iadrgseagraphembeddingandselfattentionencodingforidentifyingadversedrugreactionintheearlierphaseofdrugdevelopment